Solara Active Pharma Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 347.27 | 364.87 | 301.06 |
| Operating Expense | 285.63 | 321.25 | 412.95 |
| Net Profit | 8.02 | -12.32 | -256.40 |
| Net Profit Margin | 2.31 | -3.38 | -85.17 |
| Earning Per Share | 2.11 | -3.20 | -71.23 |
| EBIDTA | 61.64 | 43.62 | -200.68 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 347.27 |
| Operating Expense | 285.63 |
| Net Profit | 8.02 |
| Net Profit Margin | 2.31 |
| Earning Per Share | 2.11 |
| EBIDTA | 61.64 |
| Effective Tax Rate | TBA |
Invest in Solara Active Pharma Sciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,288.92 | 1,443.81 | 1,268.34 |
| Operating Expenses Annual | 1,383.98 | 1,309.77 | 1,187.99 |
| Operating Profit Annual | -279.33 | 156.18 | 95.62 |
| Interest Annual | 105.97 | 90.06 | 75.27 |
| Depreciation | 88.21 | 92.50 | 93.93 |
| Net Profit Annual | -566.87 | -22.21 | -58.56 |
| Tax Annual | 78.54 | -22.57 | -33.10 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,288.92 |
| Operating Expenses Annual | 1,383.98 |
| Operating Profit Annual | -279.33 |
| Interest Annual | 105.97 |
| Depreciation | 88.21 |
| Net Profit Annual | -566.87 |
| Tax Annual | 78.54 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 8.55 | 46.27 | 197.53 |
| Cash Flow from Operations | 110.95 | 156.17 | -241.77 |
| Cash Flow from Investing | -4.66 | -81.13 | -243.08 |
| Cash Flow from Financing | -106.52 | -112.76 | 333.59 |
| Cash Flow at the End | 8.32 | 8.55 | 46.27 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 8.55 |
| Cash Flow from Operations | 110.95 |
| Cash Flow from Investing | -4.66 |
| Cash Flow from Financing | -106.52 |
| Cash Flow at the End | 8.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -6.99 | 10.82 | 7.54 |
| PBIT Margin (%) | -14.98 | 3.14 | -1.29 |
| PBT Margin (%) | -14.84 | 3.11 | -1.27 |
| Net PROFIT Margin (%) | -43.98 | -1.54 | -4.62 |
| Return On Networth / Equity (%) | TBA | -1.47 | -3.75 |
| Return On Networth /Employed (%) | TBA | 1.74 | -0.67 |
| Return On Assets (%) | -24.63 | -0.86 | -2.40 |
| Total Debt / Equity (X) | 0.83 | 0.68 | 0.53 |
| Asset Turnover Ratio (%) | 0.56 | 0.56 | 0.52 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -6.99 |
| PBIT Margin (%) | -14.98 |
| PBT Margin (%) | -14.84 |
| Net PROFIT Margin (%) | -43.98 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -24.63 |
| Total Debt / Equity (X) | 0.83 |
| Asset Turnover Ratio (%) | 0.56 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,258.70 | 1,333.22 | 1,325 |
| Total Current Assets Annual | 790.65 | 1,190.87 | 1,239.87 |
| Non Current Assets Annual | 1,555.95 | 1,704.08 | 1,697.57 |
| Total Shareholders Funds Annual | 937.42 | 1,503.13 | 1,527.05 |
| Total Assets Annual | 2,346.60 | 2,894.95 | 2,937.44 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,258.70 |
| Total Current Assets Annual | 790.65 |
| Non Current Assets Annual | 1,555.95 |
| Total Shareholders Funds Annual | 937.42 |
| Total Assets Annual | 2,346.60 |
EPS (INR)
Expected
1.99
Reported
2.41
Surprise
21.11%
Jun 2024
EPS beaten by 21.11%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
